Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder

BJU International

Volumn 112, Issue 2, 2013, Pages 246-257

  Rahnama'I, Mohammad S ^a,b   Van Koeveringe, Gommert A ^a,b   Hohnen, Ramona ^b   Ona, Samsya ^c   Van Kerrebroeck, Philip E V ^a,b   De Wachter, Stefan G G ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

cGMP; detrusor; guinea pig; phosphodiesterase inhibitor type 5 (PDE5); urinary bladder; vardenafil

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; CALCITONIN GENE RELATED PEPTIDE; CYCLIC GMP; NEUROFILAMENT PROTEIN; NITRIC OXIDE; PHOSPHODIESTERASE V; SYNAPTIC VESICLE PROTEIN 2; UNCLASSIFIED DRUG; VARDENAFIL; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; GENE PRODUCT; GUINEA PIG; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEYDIG CELL; MALE; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UROTHELIUM;

ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; GUINEA PIGS; MALE; URINARY BLADDER;

EID: 84879690006     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12031     Document Type: Article

References (28)

1. Essayan DM,. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 2001; 108: 671-680
2. Morelli A, Filippi S, Sandner P, et al. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats. J Sex Med 2009; 6: 1594-1608
3. Gillespie JI, Drake MJ,. The actions of sodium nitroprusside and the phosphodiesterase inhibitor dipyridamole on phasic activity in the isolated guinea-pig bladder. BJU Int 2004; 93: 851-858
4. Wespes E, Amar E, Hatzichristou D, et al. EAU Guidelines on erectile dysfunction: an update. Eur Urol 2006; 49: 806-815
5. Bechara A, Romano S, Casabe A, et al. Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study. J Sex Med 2008; 5: 2170-2178
6. Morelli A, Filippi S, Sandner P, et al. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats. J Sex Med 2009; 6: 1594-1608
7. Mulhall JP, Guhring P, Parker M, et al. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 2006; 3: 662-667
8. Sairam K, Kulinskaya E, McNicholas TA, et al. Sildenafil influences lower urinary tract symptoms. BJU Int 2002; 90: 836-839
9. McVary KT, Siegel RL, Carlsson M,. Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity. Urology 2008; 72: 575-579
10. Stief CG, Porst H, Neuser D, et al. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008; 53: 1236-1244
11. Tinel H, Stelte-Ludwig B, Hutter J, et al. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU Int 2006; 98: 1259-1263
12. de Jongh R, van Koeveringe GA, van Kerrebroeck PE, et al. Alterations to network of NO/cGMP-responsive interstitial cells induced by outlet obstruction in guinea-pig bladder. Cell Tissue Res 2007; 330: 147-160
13. Rahnama'i MS, de Wachter SG, van Koeveringe GA, et al. The relationship between prostaglandin E receptor 1 and cyclooxygenase I expression in guinea pig bladder interstitial cells: proposition of a signal propagation system. J Urol 2011; 185: 315-322
14. Smet PJ, Jonavicius J, Marshall VR, et al. Distribution of nitric oxide synthase-immunoreactive nerves and identification of the cellular targets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry. Neuroscience 1996; 71: 337-348
15. Gillespie JI, Markerink-van Ittersum M, de, Vente J,. cGMP-generating cells in the bladder wall: identification of distinct networks of interstitial cells. BJU Int 2004; 94: 1114-1124
16. Monica FZ, Reges R, Cohen D, et al. Long-term administration of BAY 41-2272 prevents bladder dysfunction in nitric oxide-deficient rats. Neurourol Urodyn 2011; 30: 456-460
17. Caremel R, Oger-Roussel S, Behr-Roussel D, et al. Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat. Eur Urol 2010; 58: 616-625
18. Oger S, Behr-Roussel D, Gorny D, et al. Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle. Br J Pharmacol 2010; 160: 1135-1143
19. Morelli A, Vignozzi L, Filippi S, et al. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. Prostate 2007; 67: 234-247
20. Gacci M, Carini M, Maggi M,. Re: Christian G. Stief, Hartmut Porst, Dieter Neuser, et al. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008; 53: 1236-44. Eur Urol 2009; 55: e25-26
21. Mostafa T,. Oral phosphodiesterase type 5 inhibitors: nonerectogenic beneficial uses. J Sex Med 2008; 5: 2502-2518
22. Saenz de Tejada I, Angulo J, Cuevas P, et al. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Int J Impot Res 2001; 13: 282-290
23. Gillespie JI, van Koeveringe GA, de Wachter SG, et al. On the origins of the sensory output from the bladder: the concept of afferent noise. BJU Int 2009; 103: 1324-1333
24. McCloskey KD,. Interstitial cells in the urinary bladder-localization and function. Neurourol Urodyn 2010; 29: 82-87
25. Hashitani H, Yanai Y, Suzuki H,. Role of interstitial cells and gap junctions in the transmission of spontaneous Ca2+ signals in detrusor smooth muscles of the guinea-pig urinary bladder. J Physiol 2004; 559: 567-581
26. Vlachopoulos C, Ioakeimidis N, Rokkas K, et al. Cardiovascular effects of phosphodiesterase type 5 inhibitors. J Sex Med 2009; 6: 658-674
27. Lim KC, Tyler CM, Lim ST, et al. Proteolytic processing of proNGF is necessary for mature NGF regulated secretion from neurons. Biochem Biophys Res Commun 2007; 361: 599-604
28. Grol S, Essers PB, van, Koeveringe GA, et al. Ubiquitin hydrolase (protein gene product 9.5) in the obstructed bladder: evidence for tissue remodelling involving a subset of interstitial cells. BJU Int 2009; 104: 698-706